These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32831060)
1. HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC. Zeng H; Song X; Ji J; Chen L; Liao Q; Ma X BMC Cancer; 2020 Aug; 20(1):796. PubMed ID: 32831060 [TBL] [Abstract][Full Text] [Related]
2. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
3. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma. Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697 [TBL] [Abstract][Full Text] [Related]
4. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis. Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus. Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X Front Immunol; 2021; 12():652054. PubMed ID: 34305889 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma. Xu L; Jin Y; Qin X Int Immunopharmacol; 2020 Oct; 87():106844. PubMed ID: 32738592 [TBL] [Abstract][Full Text] [Related]
8. Type I conventional dendritic cells and CD8 Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M Front Immunol; 2024; 15():1414298. PubMed ID: 38938577 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas. Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511 [TBL] [Abstract][Full Text] [Related]
10. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma. Chen Y; Li ZY; Zhou GQ; Sun Y Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of B lymphocyte infiltration in HPV Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452 [TBL] [Abstract][Full Text] [Related]
12. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. Li J; Tang LL; Ma J BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785 [TBL] [Abstract][Full Text] [Related]
13. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments. Outh-Gauer S; Morini A; Tartour E; Lépine C; Jung AC; Badoual C Head Neck Pathol; 2020 Jun; 14(2):330-340. PubMed ID: 32124416 [TBL] [Abstract][Full Text] [Related]
14. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351 [TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557 [TBL] [Abstract][Full Text] [Related]
17. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer. Zeng H; Huang Y; Chen L; Li H; Ma X Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354 [TBL] [Abstract][Full Text] [Related]
18. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma. Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058 [TBL] [Abstract][Full Text] [Related]
19. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis. Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X Front Immunol; 2021; 12():645170. PubMed ID: 33897693 [TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]